W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza I
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Subcutaneous Glofitamab following Obinutuzumab Pretreatment in Patients with…
Miasta: Gdańsk, Poznań, WrocławWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza III
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously…
Miasta: Bydgoszcz, Gdańsk, Kraków, Lublin i 6 innych miastWiek: od 18 latSponsor: Regeneron Pharmaceuticals
W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza III
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma…
Miasta: Bydgoszcz, Gdańsk, Katowice, Kraków i 7 innych miastWiek: od 18 latSponsor: Regeneron Pharmaceuticals Inc.